Cellular and molecular parameters of mesothelioma
Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures t...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2006-07, Vol.98 (4), p.723-734 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 734 |
---|---|
container_issue | 4 |
container_start_page | 723 |
container_title | Journal of cellular biochemistry |
container_volume | 98 |
creator | Ramos-Nino, Maria E. Testa, Joseph R. Altomare, Deborah A. Pass, Harvey I. Carbone, Michele Bocchetta, Maurizio Mossman, Brooke T. |
description | Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jcb.20828 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2766267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20866398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</originalsourceid><addsrcrecordid>eNp1kMlOwzAURS0EgjIs-AHUFRKLtB4S29kgQUQLFQLEINhZrvMCgaQudsLw95i2TAtWluVzj9-7CG0T3CMY0_6jGfcollQuoQ7BqYhiHsfLqIMFwxFlhK6hde8fMcZpyugqWiNcpAkWsoNIBlXVVtp19STv1rYCM7tNtdM1NOB81xbdGrxtHqAqba030UqhKw9bi3MD3QyOrrPj6PR8eJIdnEYmiaWMcsMgSQsu5Jik0lBjcKJZIcaUmYIzIJxoYyRO8jTnlGNcsIJJ4DqEYhED20D7c--0HdeQG5g0Tldq6spau3dldan-vkzKB3VvXxQVPAhFEOwuBM4-t-AbVZfehHX1BGzrVWiMc5bKAO7NQeOs9w6K708IVp8Fq1CwmhUc2J3fU_2Qi0YD0J8Dr2UF7_-b1Cg7_FJG80TpG3j7Tmj3pMIWIlG3Z0M1uri7us7iSzVgHw4DlPM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20866398</pqid></control><display><type>article</type><title>Cellular and molecular parameters of mesothelioma</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</creator><creatorcontrib>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</creatorcontrib><description>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.20828</identifier><identifier>PMID: 16795078</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; asbestos ; Asbestos - adverse effects ; cancer ; Cell Transformation, Neoplastic ; Cell Transformation, Viral ; Humans ; mesothelioma ; Mesothelioma - diagnosis ; Mesothelioma - etiology ; Mesothelioma - metabolism ; Mesothelioma - therapy ; Mesothelioma - virology ; Peritoneal Neoplasms - diagnosis ; Peritoneal Neoplasms - etiology ; Peritoneal Neoplasms - metabolism ; Peritoneal Neoplasms - therapy ; Peritoneal Neoplasms - virology ; Pleural Neoplasms - diagnosis ; Pleural Neoplasms - etiology ; Pleural Neoplasms - metabolism ; Pleural Neoplasms - therapy ; Pleural Neoplasms - virology ; Polyomavirus Infections - diagnosis ; Polyomavirus Infections - metabolism ; Polyomavirus Infections - therapy ; Simian virus 40 ; SV40 ; Tumor Virus Infections - diagnosis ; Tumor Virus Infections - metabolism ; Tumor Virus Infections - therapy</subject><ispartof>Journal of cellular biochemistry, 2006-07, Vol.98 (4), p.723-734</ispartof><rights>Copyright © 2006 Wiley‐Liss, Inc.</rights><rights>2006 Wiley-Liss, Inc.</rights><rights>2006 Wiley-Liss, Inc. 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</citedby><cites>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.20828$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.20828$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16795078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Nino, Maria E.</creatorcontrib><creatorcontrib>Testa, Joseph R.</creatorcontrib><creatorcontrib>Altomare, Deborah A.</creatorcontrib><creatorcontrib>Pass, Harvey I.</creatorcontrib><creatorcontrib>Carbone, Michele</creatorcontrib><creatorcontrib>Bocchetta, Maurizio</creatorcontrib><creatorcontrib>Mossman, Brooke T.</creatorcontrib><title>Cellular and molecular parameters of mesothelioma</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>asbestos</subject><subject>Asbestos - adverse effects</subject><subject>cancer</subject><subject>Cell Transformation, Neoplastic</subject><subject>Cell Transformation, Viral</subject><subject>Humans</subject><subject>mesothelioma</subject><subject>Mesothelioma - diagnosis</subject><subject>Mesothelioma - etiology</subject><subject>Mesothelioma - metabolism</subject><subject>Mesothelioma - therapy</subject><subject>Mesothelioma - virology</subject><subject>Peritoneal Neoplasms - diagnosis</subject><subject>Peritoneal Neoplasms - etiology</subject><subject>Peritoneal Neoplasms - metabolism</subject><subject>Peritoneal Neoplasms - therapy</subject><subject>Peritoneal Neoplasms - virology</subject><subject>Pleural Neoplasms - diagnosis</subject><subject>Pleural Neoplasms - etiology</subject><subject>Pleural Neoplasms - metabolism</subject><subject>Pleural Neoplasms - therapy</subject><subject>Pleural Neoplasms - virology</subject><subject>Polyomavirus Infections - diagnosis</subject><subject>Polyomavirus Infections - metabolism</subject><subject>Polyomavirus Infections - therapy</subject><subject>Simian virus 40</subject><subject>SV40</subject><subject>Tumor Virus Infections - diagnosis</subject><subject>Tumor Virus Infections - metabolism</subject><subject>Tumor Virus Infections - therapy</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMlOwzAURS0EgjIs-AHUFRKLtB4S29kgQUQLFQLEINhZrvMCgaQudsLw95i2TAtWluVzj9-7CG0T3CMY0_6jGfcollQuoQ7BqYhiHsfLqIMFwxFlhK6hde8fMcZpyugqWiNcpAkWsoNIBlXVVtp19STv1rYCM7tNtdM1NOB81xbdGrxtHqAqba030UqhKw9bi3MD3QyOrrPj6PR8eJIdnEYmiaWMcsMgSQsu5Jik0lBjcKJZIcaUmYIzIJxoYyRO8jTnlGNcsIJJ4DqEYhED20D7c--0HdeQG5g0Tldq6spau3dldan-vkzKB3VvXxQVPAhFEOwuBM4-t-AbVZfehHX1BGzrVWiMc5bKAO7NQeOs9w6K708IVp8Fq1CwmhUc2J3fU_2Qi0YD0J8Dr2UF7_-b1Cg7_FJG80TpG3j7Tmj3pMIWIlG3Z0M1uri7us7iSzVgHw4DlPM</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Ramos-Nino, Maria E.</creator><creator>Testa, Joseph R.</creator><creator>Altomare, Deborah A.</creator><creator>Pass, Harvey I.</creator><creator>Carbone, Michele</creator><creator>Bocchetta, Maurizio</creator><creator>Mossman, Brooke T.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20060701</creationdate><title>Cellular and molecular parameters of mesothelioma</title><author>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>asbestos</topic><topic>Asbestos - adverse effects</topic><topic>cancer</topic><topic>Cell Transformation, Neoplastic</topic><topic>Cell Transformation, Viral</topic><topic>Humans</topic><topic>mesothelioma</topic><topic>Mesothelioma - diagnosis</topic><topic>Mesothelioma - etiology</topic><topic>Mesothelioma - metabolism</topic><topic>Mesothelioma - therapy</topic><topic>Mesothelioma - virology</topic><topic>Peritoneal Neoplasms - diagnosis</topic><topic>Peritoneal Neoplasms - etiology</topic><topic>Peritoneal Neoplasms - metabolism</topic><topic>Peritoneal Neoplasms - therapy</topic><topic>Peritoneal Neoplasms - virology</topic><topic>Pleural Neoplasms - diagnosis</topic><topic>Pleural Neoplasms - etiology</topic><topic>Pleural Neoplasms - metabolism</topic><topic>Pleural Neoplasms - therapy</topic><topic>Pleural Neoplasms - virology</topic><topic>Polyomavirus Infections - diagnosis</topic><topic>Polyomavirus Infections - metabolism</topic><topic>Polyomavirus Infections - therapy</topic><topic>Simian virus 40</topic><topic>SV40</topic><topic>Tumor Virus Infections - diagnosis</topic><topic>Tumor Virus Infections - metabolism</topic><topic>Tumor Virus Infections - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Nino, Maria E.</creatorcontrib><creatorcontrib>Testa, Joseph R.</creatorcontrib><creatorcontrib>Altomare, Deborah A.</creatorcontrib><creatorcontrib>Pass, Harvey I.</creatorcontrib><creatorcontrib>Carbone, Michele</creatorcontrib><creatorcontrib>Bocchetta, Maurizio</creatorcontrib><creatorcontrib>Mossman, Brooke T.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Nino, Maria E.</au><au>Testa, Joseph R.</au><au>Altomare, Deborah A.</au><au>Pass, Harvey I.</au><au>Carbone, Michele</au><au>Bocchetta, Maurizio</au><au>Mossman, Brooke T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cellular and molecular parameters of mesothelioma</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>98</volume><issue>4</issue><spage>723</spage><epage>734</epage><pages>723-734</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16795078</pmid><doi>10.1002/jcb.20828</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2006-07, Vol.98 (4), p.723-734 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2766267 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Animals asbestos Asbestos - adverse effects cancer Cell Transformation, Neoplastic Cell Transformation, Viral Humans mesothelioma Mesothelioma - diagnosis Mesothelioma - etiology Mesothelioma - metabolism Mesothelioma - therapy Mesothelioma - virology Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - etiology Peritoneal Neoplasms - metabolism Peritoneal Neoplasms - therapy Peritoneal Neoplasms - virology Pleural Neoplasms - diagnosis Pleural Neoplasms - etiology Pleural Neoplasms - metabolism Pleural Neoplasms - therapy Pleural Neoplasms - virology Polyomavirus Infections - diagnosis Polyomavirus Infections - metabolism Polyomavirus Infections - therapy Simian virus 40 SV40 Tumor Virus Infections - diagnosis Tumor Virus Infections - metabolism Tumor Virus Infections - therapy |
title | Cellular and molecular parameters of mesothelioma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T13%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cellular%20and%20molecular%20parameters%20of%20mesothelioma&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Ramos-Nino,%20Maria%20E.&rft.date=2006-07-01&rft.volume=98&rft.issue=4&rft.spage=723&rft.epage=734&rft.pages=723-734&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.20828&rft_dat=%3Cproquest_pubme%3E20866398%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20866398&rft_id=info:pmid/16795078&rfr_iscdi=true |